Medicine
Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer
Ma Dong
tlooto Summary
The results of a key Phase III trial showed that adding bevaciuzmab to chemotherapy significantly improves survival among patients with previously untreated metastatic colorectal cancer.
Abstract
Abstract is not available.
Citation format
DONG, Ma. Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer. Journal of Evidence Based Medicine, 2006.